Long-term growth hormone check for children with short stature
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 2 years old
- Be diagnosed with short height due to one of these causes: GHD, TS, CRF, SGA, or ISS (the study uses these medical terms)
- Have a condition that fits one of the listed categories: GHD, TS, CRF, SGA, or ISS
- You (or your parent/legal guardian) can give written consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This study looks at how the body’s growth signals (growth hormone and related proteins) work in children. It may help researchers understand growth differences in kids who are healthy or have certain growth-related conditions.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
This trial studies how different types of growth hormone treatment affect growth and metabolism in children with growth hormone deficiency. It helps compare standard treatment with a long-acting type and looks at growth and metabolic changes.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
Hear when a new Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.